Literature DB >> 1792646

Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma.

L M Kuitert1, A C Harrison.   

Abstract

A 32 year old man with chronic severe asthma, requiring maintenance oral corticosteroids, was started on a weekly dose of methotrexate. Eleven weeks later he developed Pneumocystis carinii pneumonia. In the two years following treatment there has been no recurrence while oral corticosteroid treatment has been continued. Pneumocystis pneumonia should be considered in asthmatic patients taking methotrexate who present with fever, pulmonary infiltrates, and hypoxia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1792646      PMCID: PMC463505          DOI: 10.1136/thx.46.12.936

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  8 in total

1.  Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma.

Authors:  R J Shiner; A J Nunn; K F Chung; D M Geddes
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

2.  Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriatic arthropathy.

Authors:  P J Wallis; K S Ryatt; T J Constable
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

3.  Rheumatoid arthritis, methotrexate therapy, and Pneumocystis pneumonia.

Authors:  R L Leff; J P Case
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

Review 4.  Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.

Authors:  A Wollner; J Mohle-Boetani; R E Lambert; J L Perruquet; T A Raffin; J L McGuire
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

5.  Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis.

Authors:  E W St Clair; J R Rice; R Snyderman
Journal:  Arch Intern Med       Date:  1985-11

6.  Immunologic studies of rheumatoid arthritis patients treated with methotrexate.

Authors:  N J Olsen; L F Callahan; T Pincus
Journal:  Arthritis Rheum       Date:  1987-05

7.  Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study.

Authors:  M F Mullarkey; B A Blumenstein; W P Andrade; G A Bailey; I Olason; C E Wetzel
Journal:  N Engl J Med       Date:  1988-03-10       Impact factor: 91.245

8.  Long-term methotrexate treatment in corticosteroid-dependent asthma.

Authors:  M F Mullarkey; J K Lammert; B A Blumenstein
Journal:  Ann Intern Med       Date:  1990-04-15       Impact factor: 25.391

  8 in total
  4 in total

Review 1.  A risk-benefit assessment of methotrexate in corticosteroid-dependent asthma.

Authors:  T R Shulimzon; R J Shiner
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

Review 2.  Corticosteroid sparing agents in asthma.

Authors:  J M Hill; A E Tattersfield
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

Review 3.  Methotrexate in asthma. A safety perspective.

Authors:  P G Bardin; D J Fraenkel; R W Beasley
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

4.  Fatal chickenpox pneumonia in an asthmatic patient on oral steroids and methotrexate.

Authors:  A A Gatnash; C K Connolly
Journal:  Thorax       Date:  1995-04       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.